[Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration]. 1988

N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
Service de Médecine interne, Hôpital Bichat, Paris.

Pharmacokinetic values of prednisone and prednisolone were measured in the serum of 6 healthy volunteers after oral administration of either prednisolone methylsulfobenzoate 30 mg or prednisone 30 mg. Peak serum concentrations of prednisolone obtained after dosing with prednisone occurred earlier and were higher (473 +/- 106 ng/ml) than those obtained after dosing with prednisolone methylsulfobenzoate (232 +/- 70 ng/ml; P less than 0.01). Similarly, areas under the 0-8 h concentration curves were significantly greater after dosing with prednisone than after dosing with prednisolone methylsulfobenzoate (prednisolone: P less than 0.001; prednisone: P less than 0.02). The differences may be due to prednisolone methylsulfobenzoate not being absorbed as well as prednisone. These kinetic data may warrant a reappraisal of the therapeutic equivalence of the two drugs taken for granted in France.

UI MeSH Term Description Entries
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013810 Therapeutic Equivalency The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease. Bioequivalence,Clinical Equivalency,Equivalency, Therapeutic,Generic Equivalency,Clinical Equivalencies,Equivalencies, Clinical,Equivalencies, Therapeutic,Equivalency, Clinical,Therapeutic Equivalencies,Bioequivalences,Equivalencies, Generic,Equivalency, Generic,Generic Equivalencies

Related Publications

N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
July 1976, Journal of pharmaceutical sciences,
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
May 2023, British journal of clinical pharmacology,
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
December 2005, Journal of acquired immune deficiency syndromes (1999),
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
September 1992, International journal of clinical pharmacology, therapy, and toxicology,
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
October 1997, Journal of clinical pharmacology,
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
January 1983, European journal of clinical pharmacology,
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
January 1984, International journal of clinical pharmacology, therapy, and toxicology,
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
January 1984, Pharmaceutica acta Helvetiae,
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
August 1990, Clinical pharmacokinetics,
N Brion, and M L Pibarot, and P Atienza, and P Robin, and C Carbon
January 1979, Clinical pharmacokinetics,
Copied contents to your clipboard!